Ralf Liebhold / Shutterstock.com
22 June 2023AmericasMuireann Bolger
Bausch targets Israeli firm in skin treatment dispute
Pharma company claims infringement of both patents that cover the blockbuster treatment | Generic version has been in motion since May last year.
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
Big Pharma
20 June 2023 Pharma giant claims infringement of two patents |
Hyderabad-based rival’s letter offering details of proposed generic allegedly lacked certain required details.
Americas
18 August 2022 New Jersey court dismissed a suit regarding an oral antibiotic | Prior art invalidated plaintiff’s four patents.
Editor's picks
Editor's picks
Big Pharma
20 June 2023 Pharma giant claims infringement of two patents |
Hyderabad-based rival’s letter offering details of proposed generic allegedly lacked certain required details.
Americas
18 August 2022 New Jersey court dismissed a suit regarding an oral antibiotic | Prior art invalidated plaintiff’s four patents.
Big Pharma
20 June 2023 Pharma giant claims infringement of two patents |
Hyderabad-based rival’s letter offering details of proposed generic allegedly lacked certain required details.
Americas
18 August 2022 New Jersey court dismissed a suit regarding an oral antibiotic | Prior art invalidated plaintiff’s four patents.